SCHEMBL14853916

SCHEMBL14853916

Cc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(Cl)Cl)C(O)C1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 7/20 0.64
▸ DNPH1 O43598 4/20 0.64
▸ P2RY2 P41231 3/20 0.64
▸ TAS1R3 Q7RTX0 3/20 0.64
▸ TAS1R1 Q7RTX1 3/20 0.64
▸ ADORA1 P30542 3/20 0.64
▸ SRC P12931 2/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ TRPM2 O94759 2/20 0.64
▸ P2RY11 Q96G91 2/20 0.64
▸ PRKAB2 O43741 1/20 0.64
▸ LDHA P00338 1/20 0.64
▸ ADRB2 P07550 1/20 0.64
▸ FBP1 P09467 1/20 0.64
▸ PRKAG1 P54619 1/20 0.64
▸ PRKAA2 P54646 1/20 0.64
▸ PDE4D Q08499 1/20 0.64
▸ KCNH2 Q12809 1/20 0.64
▸ PRKAA1 Q13131 1/20 0.64
▸ PDE3A Q14432 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13995541 0.91 DNPH1 (0.77) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL10295496 0.90 P2RY1 (0.67) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL14929511 0.88 P2RY1 (0.66) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL18574268 0.88 P2RY1 (0.66) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL14946362 0.88 P2RY1 (0.66) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL10630694 0.88 P2RY1 (0.83) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL10630676 0.88 P2RY1 (0.83) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL10295499 0.86 P2RY1 (0.71) P2RY1DNPH1P2RY2TAS1R3TAS1R1
SCHEMBL13853911 0.86 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL29995120 0.86 P2RY1 (0.74) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013052523-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF modeRNA Therapeutics (US) 2013-04-11 — — WO disclosed
Send feedback